BioCentury | Oct 10, 2019
Financial News
Oct. 9 Financial Quick Takes: BioNTech, DBV, MiroBio, Hrain, Beijing Gene+, Ginkgo
...in Phase I testing in China for multiple myeloma. Yangming Capital, Junchenda Capital, Zhanglong Haifa, Shanghai Yongrun Investment...
